Skip to content

Caribou Biosciences, Inc.

CRBU

CIK 0001619856 · Biological Products, (No Diagnostic Substances) · Nasdaq

← back to feed
Revenue (TTM)
$9.62M
+11.7% YoY Q1 Apr 2026
Net Income (TTM)
−$146.72M
+0.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.57
+3.6% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-1,520.2%
Q1 Apr 2026
Net Margin
-1,526.0%
Q1 Apr 2026
Free Cash Flow (TTM)
−$133.44M
Q1 Apr 2026
Cash
$12.06M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
99.18M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings